DA5221-B2

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA5221-B2, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]

See pricing